Survival in Patients with Liver Cirrhosis: A Prospective Study.

Elena Curakova Ristovska, Magdalena Genadieva-Dimitrova, Beti Todorovska
{"title":"Survival in Patients with Liver Cirrhosis: A Prospective Study.","authors":"Elena Curakova Ristovska, Magdalena Genadieva-Dimitrova, Beti Todorovska","doi":"10.2478/prilozi-2023-0045","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction</b>: The differences in the survival time of cirrhotic patients reported by different studies are probably caused by the influence of many contributing factors. The aim of the study was to evaluate the survival over a one-year period, to register the occurrence of acute decompensation (AD) and to determine the most frequent causes of death. <b>Material and methods</b>: Out of 71 patients enrolled in the study, 63 completed the prospective one-year follow-up. During the follow-up, we evaluated the occurrence of AD, the causes of death, and we registered three-month, six-month and one-year survival regarding the AD status at presentation. <b>Results</b>: Of the 63 patients, 24 (38.09%) died before the end of the study (14 patients before the end of three months, 6 before the end of six months and 4 patients before the end of one year). The overall survival was 38.09% and the mean survival time was 108 ± 98.53 days. The most prevalent cause of death was bleeding from esophageal varices (5 patients, 20.83%). AD patients had a significantly shorter survival than patients without AD (97±90.54 vs. 229±138.59) and 78.57% of them died during the follow-up. The estimated six-month and one-year median survival time were 272.8 [95% CI (238.4-307.2)] and 267.1 [95% CI (232.9-301.2)] days, respectively. The six-month and one-year survival were significantly shorter in AD patients (p<0.0001). <b>Conclusion</b>: The etiology, stage of liver disease and the presence of AD are important factors that influence on the survival in cirrhotic patients.</p>","PeriodicalId":74492,"journal":{"name":"Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)","volume":"44 3","pages":"41-47"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2478/prilozi-2023-0045","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/1 0:00:00","PubModel":"Print","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The differences in the survival time of cirrhotic patients reported by different studies are probably caused by the influence of many contributing factors. The aim of the study was to evaluate the survival over a one-year period, to register the occurrence of acute decompensation (AD) and to determine the most frequent causes of death. Material and methods: Out of 71 patients enrolled in the study, 63 completed the prospective one-year follow-up. During the follow-up, we evaluated the occurrence of AD, the causes of death, and we registered three-month, six-month and one-year survival regarding the AD status at presentation. Results: Of the 63 patients, 24 (38.09%) died before the end of the study (14 patients before the end of three months, 6 before the end of six months and 4 patients before the end of one year). The overall survival was 38.09% and the mean survival time was 108 ± 98.53 days. The most prevalent cause of death was bleeding from esophageal varices (5 patients, 20.83%). AD patients had a significantly shorter survival than patients without AD (97±90.54 vs. 229±138.59) and 78.57% of them died during the follow-up. The estimated six-month and one-year median survival time were 272.8 [95% CI (238.4-307.2)] and 267.1 [95% CI (232.9-301.2)] days, respectively. The six-month and one-year survival were significantly shorter in AD patients (p<0.0001). Conclusion: The etiology, stage of liver disease and the presence of AD are important factors that influence on the survival in cirrhotic patients.

肝硬化患者的存活率:前瞻性研究
导言不同研究报告中肝硬化患者存活时间的差异可能是由多种因素造成的。本研究旨在评估肝硬化患者一年内的存活率,登记急性失代偿(AD)的发生率,并确定最常见的死亡原因。材料和方法在 71 名参与研究的患者中,63 人完成了为期一年的前瞻性随访。在随访期间,我们评估了急性失代偿的发生率、死亡原因,并登记了与发病时急性失代偿状态有关的三个月、六个月和一年的存活率。结果显示63 名患者中有 24 人(38.09%)在研究结束前死亡(14 人在三个月前死亡,6 人在六个月前死亡,4 人在一年前死亡)。总存活率为 38.09%,平均存活时间为 108 ± 98.53 天。最常见的死亡原因是食道静脉曲张出血(5 名患者,20.83%)。AD 患者的生存期明显短于无 AD 患者(97±90.54 对 229±138.59),其中 78.57% 的患者在随访期间死亡。估计的六个月和一年中位生存时间分别为 272.8 [95% CI (238.4-307.2)] 天和 267.1 [95% CI (232.9-301.2)] 天。AD患者的6个月和1年存活期明显更短(p结论:病因、肝病阶段和 AD 的存在是影响肝硬化患者存活率的重要因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信